A device implanted into mice can modulate brain circuit activity over long periods of time.

Unlike biotech tools adapted from nature, the invention was entirely conceived by humans and represents one of the few proteins made from scratch in the lab.

Executives at a biotech that develops new antibodies argue that Ram Sasisekharan didn’t come up with the structures for at least two experimental therapies that his group has described.

The pharmaceutical industry is looking to machine learning to overcome complex challenges in drug development.

Deep-learning algorithms could help doctors narrow in on the causes of certain medical conditions, say researchers.

The documentary weaves together a hunt for mammoth tusks in the Arctic with scenes from the front lines of synthetic biology.

The country is the second in Africa to permit cannabis cultivation, but months after approval there’s been little uptake by farmers and no scientific proposals.

The genetically engineered probiotic, already in clinical trials, may ease patients’ strict dietary regimes.

In an ongoing legal battle, the University of California, Berkeley has challenged the Broad Institute’s patent claims on the gene editing technology.